Stock Events

Stock Events

AcuityAds 

0
140
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q1 2026
Next
-0.05
-0.05
-0.04
-0.04
Expected EPS
-0.051280328211199995
Actual EPS
N/A

Financials

-10.21%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
89.53MRevenue
-9.14MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow K3S.MU. It's not an investment recommendation.
Toronto Dominion Bank
8
TD.TO
Royal Bank Of Canada
8
RY.TO
Enbridge
7
ENB.TO
Vanguard S&P 500 Index
7
VFV.TO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap28.78B
Illumina, Inc. is a direct competitor in the genomic sequencing space, offering similar sequencing and array technologies.
Thermo Fisher Scientific
TMO
Mkt Cap195.86B
Thermo Fisher Scientific provides comprehensive solutions including instruments, reagents, and software for research, analysis, discovery, and diagnostics that compete with Illumin's offerings.
Pacific Biosciences of California
PACB
Mkt Cap484.54M
Pacific Biosciences of California offers long-read sequencing technologies that compete with Illumin's short-read sequencing platforms.
Bio-Rad Laboratories
BIO
Mkt Cap7.92B
Bio-Rad Laboratories, Inc. offers a range of products for the life science research and clinical diagnostics markets, competing in the genomic and molecular diagnostics space.
Qiagen NV
QGEN
Mkt Cap8.56B
Qiagen N.V. provides sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the nucleic acid solutions market.
Agilent Technologies
A
Mkt Cap37.93B
Agilent Technologies, Inc. provides instruments, software, services, and consumables for the entire laboratory workflow, competing with Illumin in the genomics and molecular diagnostics sectors.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG offers diagnostic and research tools that compete with Illumin's genomic solutions, particularly in the sequencing and array-based technologies.
Quest Diagnostics
DGX
Mkt Cap22.96B
Quest Diagnostics incorporates genomic sequencing into its diagnostic testing services, competing indirectly with Illumin by offering similar diagnostic solutions.
Intellia Therapeutics
NTLA
Mkt Cap1.99B
Intellia Therapeutics, Inc. is involved in CRISPR/Cas9 technology, a gene editing technology that requires sequencing, indirectly competing with Illumin's sequencing technologies.
Editas Medicine
EDIT
Mkt Cap500.29M
Editas Medicine, Inc. also works in the gene editing space with CRISPR technology, relying on genomic sequencing technologies similar to those offered by Illumin for its research and development.

About

illumin Holdings Inc., a technology company, provides digital media solutions in Canada, the United States, Europe, Latin America, and internationally. The company offers a programmatic marketing platform that enables advertisers to connect with their audiences across video, mobile, out-of-home, social, CTV and online display advertising campaigns. Its platform also allows advertisers to manage their purchasing of online display advertising in real-time using programmatic ad buying. In addition, the company offers illumin platform, an advertising automation technology that provides planning, media buying, and omnichannel intelligence, as well as allows advertisers to map their consumer journey playbooks across screens and execute in real-time using programmatic technology. It serves Fortune 500 enterprises and small to mid-sized businesses. The company was formerly known as AcuityAds Holdings Inc. and changed its name to illumin Holdings Inc. in June 2023. illumin Holdings Inc. was founded in 2009 and is headquartered in Toronto, Canada.
Show more...
CEO
Mr. Tal Hayek
Employees
196
Country
Canada
ISIN
CA00510L1067

Listings

MU
DE
K3S0.MU
MU
DE
K3S.MU
STU
DE
K3S0.STU
STU
DE
K3S.STU

0 Comments

Share your thoughts

FAQ

What is AcuityAds stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange AcuityAds stocks are traded under the ticker K3S.MU.
When is the next AcuityAds earnings date?▼
AcuityAds is going to release the next earnings report on August 06, 2026.
What were AcuityAds earnings last quarter?▼
K3S.MU earnings for the last quarter are -0.04 EUR per share, whereas the estimation was -0.04 EUR resulting in a +14.29% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is AcuityAds revenue for the last year?▼
AcuityAds revenue for the last year amounts to 89.53M EUR.
What is AcuityAds net income for the last year?▼
K3S.MU net income for the last year is -9.14M EUR.
How many employees does AcuityAds have?▼
As of July 19, 2026, the company has 196 employees.
In which sector is AcuityAds located?▼
AcuityAds operates in the Communication sector.
When did AcuityAds complete a stock split?▼
AcuityAds has not had any recent stock splits.
Where is AcuityAds headquartered?▼
AcuityAds is headquartered in Toronto, Canada.